Prices of 108 diabetes, cardiac formulations fixed: NPPA
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Atorvastatin Calcium | Biotechnology | Diabetes | Endocrinology | Glimepiride | Lipitor | Metolazone | Pharmaceuticals | Statin Therapy | Zivast